Study identifier:D9584C00004
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Omeprazole versus anti-reflux surgery in the long-term management of peptic esophagitis – a 10 year follow up study of patients previously studied for 5 years – A Nordic multicentre study
GERD
Phase 3
No
Omeprazole
All
219
Interventional
18 Years +
Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Verified 01 Apr 2015 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|